Skip to main content
FDA committee backs GlaxoSmithKline's tafenoquine tablets for malaria
7/13/2018

GlaxoSmithKline's tafenoquine tablets received a positive opinion from the FDA's Antimicrobial Drugs Advisory Committee, thus recommending tafenoquine for approval. The drug was developed as a radical cure and preventive medication for relapse of malaria caused by Plasmodium vivax.

Full Story: